ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
13.42
-0.01 (-0.07%)
Oct 29, 2025, 1:32 PM EDT - Market open
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.3 billion as of October 29, 2025. Its market cap has increased by 98.04% in one year.
Market Cap
1.30B
Enterprise Value
1.03B
1-Year Change
98.04%
Ranking
Category
Stock Price
$13.42
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.30B, an increase of 75.66%. That is a compound annual growth rate of 10.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 1.30B | 129.05% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.38B |
| Johnson & Johnson | 447.26B |
| AbbVie | 399.26B |
| UnitedHealth Group | 330.05B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Merck & Co. | 218.23B |